Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond monotherapy: rational polytherapy in migraine

S J Peroutka1

  • 1Spectra Biomedical, Inc, Burlingame, CA 94010, USA.

Headache
|March 20, 1998
PubMed
Summary

Migraine treatment may improve by combining therapies targeting dopamine, inflammation, and serotonin (5-HT) pathways. This polytherapy approach offers a rationale for enhanced migraine relief beyond single-drug treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Demographic Analysis of Industry-Sponsored Alzheimer's Disease Trial Populations in the United States.

The journal of prevention of Alzheimer's disease·2023
Same author

"Specific" [(3)H]8-OH-DPAT binding to glass fiber filter paper: Implications for the analysis of serotonin binding site subtypes.

Neurochemistry international·2010
Same author

About the so-called specific binding of [(3)H]8-OH-DPAT to glass fiber filter.

Neurochemistry international·2010
Same author

Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.

Genomics·2001
Same author

Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus.

Genomics·2001
Same author

Analysis of Internet sites for headache.

Cephalalgia : an international journal of headache·2001

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine pathophysiology involves dopaminergic hypersensitivity, inflammation, and low serotonin (5-HT) levels.
  • Current monotherapies targeting these pathways offer incomplete relief for many patients.

Purpose of the Study:

  • To explore the rationale for combining therapies targeting dopamine, inflammation, and 5-HT receptors for migraine.
  • To present the scientific basis for polytherapy in migraine management.

Main Methods:

  • Review of existing scientific and clinical data on migraine pathophysiology.
  • Analysis of the mechanisms of action for dopamine antagonists, anti-inflammatory agents, and 5-HT1 agonists.

Main Results:

  • Monotherapy targeting single pathophysiological features is often suboptimal.
  • Concurrent modulation of multiple biological systems is hypothesized to be more efficacious.

Conclusions:

  • Combining dopamine antagonists, anti-inflammatory agents, and 5-HT1 agonists is a logical approach for improved migraine treatment.
  • Polytherapy offers a potential strategy to achieve rapid, consistent, and complete migraine relief.

Related Experiment Videos